BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 32600092)

  • 1. Leaky memories: Impact of
    Li W; Lo EH
    J Cereb Blood Flow Metab; 2020 Sep; 40(9):1912-1914. PubMed ID: 32600092
    [TBL] [Abstract][Full Text] [Related]  

  • 2. APOE4 leads to blood-brain barrier dysfunction predicting cognitive decline.
    Montagne A; Nation DA; Sagare AP; Barisano G; Sweeney MD; Chakhoyan A; Pachicano M; Joe E; Nelson AR; D'Orazio LM; Buennagel DP; Harrington MG; Benzinger TLS; Fagan AM; Ringman JM; Schneider LS; Morris JC; Reiman EM; Caselli RJ; Chui HC; Tcw J; Chen Y; Pa J; Conti PS; Law M; Toga AW; Zlokovic BV
    Nature; 2020 May; 581(7806):71-76. PubMed ID: 32376954
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Accelerated pericyte degeneration and blood-brain barrier breakdown in apolipoprotein E4 carriers with Alzheimer's disease.
    Halliday MR; Rege SV; Ma Q; Zhao Z; Miller CA; Winkler EA; Zlokovic BV
    J Cereb Blood Flow Metab; 2016 Jan; 36(1):216-27. PubMed ID: 25757756
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In Thai Nationals, the ApoE4 Allele Affects Multiple Domains of Neuropsychological, Biobehavioral, and Social Functioning Thereby Contributing to Alzheimer's Disorder, while the ApoE3 Allele Protects Against Neuropsychiatric Symptoms and Psychosocial Deficits.
    Tangwongchai S; Supasitthumrong T; Hemrunroj S; Tunvirachaisakul C; Chuchuen P; Houngngam N; Snabboon T; Tawankanjanachot I; Likitchareon Y; Phanthumchindad K; Maes M
    Mol Neurobiol; 2018 Aug; 55(8):6449-6462. PubMed ID: 29307083
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peripheral Inflammation, Apolipoprotein E4, and Amyloid-β Interact to Induce Cognitive and Cerebrovascular Dysfunction.
    Marottoli FM; Katsumata Y; Koster KP; Thomas R; Fardo DW; Tai LM
    ASN Neuro; 2017; 9(4):1759091417719201. PubMed ID: 28707482
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A "multi-omics" analysis of blood-brain barrier and synaptic dysfunction in APOE4 mice.
    Barisano G; Kisler K; Wilkinson B; Nikolakopoulou AM; Sagare AP; Wang Y; Gilliam W; Huuskonen MT; Hung ST; Ichida JK; Gao F; Coba MP; Zlokovic BV
    J Exp Med; 2022 Nov; 219(11):. PubMed ID: 36040482
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ApoE4-mediated blood-brain barrier damage in Alzheimer's disease: Progress and prospects.
    Zhou X; Shi Q; Zhang X; Gu L; Li J; Quan S; Zhao X; Li Q
    Brain Res Bull; 2023 Jul; 199():110670. PubMed ID: 37224887
    [TBL] [Abstract][Full Text] [Related]  

  • 8. How Alpha Linolenic Acid May Sustain Blood-Brain Barrier Integrity and Boost Brain Resilience against Alzheimer's Disease.
    Leikin-Frenkel A; Schnaider Beeri M; Cooper I
    Nutrients; 2022 Nov; 14(23):. PubMed ID: 36501121
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Little genomic support for Cyclophilin A-matrix metalloproteinase-9 pathway as a therapeutic target for cognitive impairment in APOE4 carriers.
    Anderson EL; Williams DM; Walker VM; Davies NM
    Sci Rep; 2022 Jan; 12(1):1057. PubMed ID: 35058547
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Precision Nutrition for Alzheimer's Prevention in
    Norwitz NG; Saif N; Ariza IE; Isaacson RS
    Nutrients; 2021 Apr; 13(4):. PubMed ID: 33921683
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peripheral Blood Biomarkers Coupled with the Apolipoprotein E4 Genotype Are Strongly Associated with Semantic and Episodic Memory Impairments in Elderly Subjects with Amnestic Mild Cognitive Impairment and Alzheimer's Disease.
    Supasitthumrong T; Tunvirachaisakul C; Aniwattanapong D; Tangwongchai S; Chuchuen P; Tawankanjanachot I; Snabboon T; Hemrungrojn S; Carvalho AF; Maes M
    J Alzheimers Dis; 2019; 71(3):797-811. PubMed ID: 31424390
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NIH-funded research provides new clues on how ApoE4 affects Alzheimer's risk.
    Am J Alzheimers Dis Other Demen; 2012 Aug; 27(5):356-7. PubMed ID: 22991704
    [No Abstract]   [Full Text] [Related]  

  • 13. Hippocampal blood-brain barrier permeability is related to the APOE4 mutation status of elderly individuals without dementia.
    Moon WJ; Lim C; Ha IH; Kim Y; Moon Y; Kim HJ; Han SH
    J Cereb Blood Flow Metab; 2021 Jun; 41(6):1351-1361. PubMed ID: 32936729
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterizing Apolipoprotein E ε4 Carriers and Noncarriers With the Clinical Diagnosis of Mild to Moderate Alzheimer Dementia and Minimal β-Amyloid Peptide Plaques.
    Monsell SE; Kukull WA; Roher AE; Maarouf CL; Serrano G; Beach TG; Caselli RJ; Montine TJ; Reiman EM
    JAMA Neurol; 2015 Oct; 72(10):1124-31. PubMed ID: 26302353
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Co-Expression of Glia Maturation Factor and Apolipoprotein E4 in Alzheimer's Disease Brain.
    Thangavel R; Bhagavan SM; Ramaswamy SB; Surpur S; Govindarajan R; Kempuraj D; Zaheer S; Raikwar S; Ahmed ME; Selvakumar GP; Iyer SS; Zaheer A
    J Alzheimers Dis; 2018; 61(2):553-560. PubMed ID: 29172001
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Abeta-independent roles of apolipoprotein E4 in the pathogenesis of Alzheimer's disease.
    Huang Y
    Trends Mol Med; 2010 Jun; 16(6):287-94. PubMed ID: 20537952
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Apolipoprotein ɛ4 is Associated with Dementia and Cognitive Impairment Predominantly Due to Alzheimer's Disease and Not with Vascular Cognitive Impairment: A Singapore-Based Cohort.
    Chai YL; Yeo HK; Wang J; Hilal S; Ikram MK; Venketasubramanian N; Wong BS; Chen CL
    J Alzheimers Dis; 2016; 51(4):1111-8. PubMed ID: 26923016
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of Asymmetrical White Matter Hyperintensities and Apolipoprotein E4 on Cognitive Impairment.
    Low A; Ng KP; Chander RJ; Wong B; Kandiah N
    J Alzheimers Dis; 2019; 70(3):953-964. PubMed ID: 31306121
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rapamycin rescues vascular, metabolic and learning deficits in apolipoprotein E4 transgenic mice with pre-symptomatic Alzheimer's disease.
    Lin AL; Jahrling JB; Zhang W; DeRosa N; Bakshi V; Romero P; Galvan V; Richardson A
    J Cereb Blood Flow Metab; 2017 Jan; 37(1):217-226. PubMed ID: 26721390
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gene-environment interaction between lead and Apolipoprotein E4 causes cognitive behavior deficits in mice.
    Engstrom AK; Snyder JM; Maeda N; Xia Z
    Mol Neurodegener; 2017 Feb; 12(1):14. PubMed ID: 28173832
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.